Abstract
Antidepressant medications generally are considered to have a delayed onset of action; however, recent evidence is beginning to challenge this conventional wisdom. Meta-analysis of placebo-controlled, randomized trials reveals that patients with depression are more likely to experience a clinically significant response with antidepressants than with placebo by the end of the first week of treatment. About one third of the total treatment benefit over 6 weeks is evident by the end of the first week. Early response to antidepressants is not necessarily a placebo response.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References and Recommended Reading
NICE: National Institute for Clinical Evidence Clinical Guideline 23. Depression: Management of Depression in Primary and Secondary Care. London: NICE; 2004.
Kuhn R: [Treatment of depressive states with an iminodibenzyl derivative (G 22355).]. Schweiz Med Wochenschr 1957, 87:1135–1140.
Trivedi MH, Rush AJ, Wisniewski SR, et al.: Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 2006, 163:28–40.
Taylor MJ, Freemantle N, Geddes JR, Bhagwagar Z: Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis. Arch Gen Psychiatry 2006, 63:1217–1223.
Moeller HJ, Mueller H, Volz HP: How to assess the onset of antidepressant effect: comparison of global ratings and findings based on depression scales. Pharmacopsychiatry 1996, 29:57–62.
McIntyre RS, O’Donovan C. The human cost of not achieving full remission in depression. Can J Psychiatry 2004, 49(Suppl 1):10S–16S.
Quitkin FM, Rabkin JG, Ross D, Stewart JW: Identification of true drug response to antidepressants. Use of pattern analysis. Arch Gen Psychiatry 1984, 41:782–786.
Quitkin FM, Rabkin JD, Markowitz JM, et al.: Use of pattern analysis to identify true drug response. A replication. Arch Gen Psychiatry 1987, 44:259–264.
Papakostas GI, Perlis RH, Scalia MJ, et al.: A meta-analysis of early sustained response rates between antidepressants and placebo for the treatment of major depressive disorder. J Clin Psychopharmacol 2006, 26:56–60.
Campbell MJ, Julious SA, Altman DG: Estimating sample sizes for binary, ordered categorical, and continuous outcomes in two group comparisons. BMJ 1995, 311:1145–1148.
Priest RG, Hawley CJ, Kibel D, et al.: Recovery from depressive illness does fit an exponential model. J Clin Psychopharmacol 1996, 16:420–424.
van der Werf SY, Kaptein KI, de Jonge P, et al.: Major depressive episodes and random mood. Arch Gen Psychiatry 2006, 63:509–518.
Geddes JR, Carney SM, Davies C, et al.: Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet 2003, 361:653–661.
Stewart JW, Quitkin FM, McGrath PJ, et al.: Use of pattern analysis to predict differential relapse of remitted patients with major depression during 1 year of treatment with fluoxetine or placebo. Arch Gen Psychiatry 1998, 55:334–343.
McGrath PJ, Stewart JW, Quitkin FM, et al.: Predictors of relapse in a prospective study of fluoxetine treatment of major depression. Am J Psychiatry 2006, 163:1542–1548.
Harmer CJ, Shelley NC, Cowen PJ, Goodwin GM: Increased positive versus negative affective perception and memory in healthy volunteers following selective serotonin and norepinephrine reuptake inhibition. Am J Psychiatry 2004, 161:1256–1263.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Taylor, M.J. Rapid onset of true antidepressant action. Curr Psychiatry Rep 9, 475–479 (2007). https://doi.org/10.1007/s11920-007-0064-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11920-007-0064-0